Status:
UNKNOWN
Effect of Spinae Erector Block (ESP) and Gabapentin on Recovery and Length of Stay in Adolescent Spinal Fusion Patients
Lead Sponsor:
Hospital Italiano de Buenos Aires
Conditions:
Adolescent Idiopathic Scoliosis
Eligibility:
All Genders
Up to 18 years
Brief Summary
A retrospective cohort study comparing time to ambulation (hours) between two groups of adolescent spinal fusion patients: a group who received intravenous multimodal analgesic strategy alone (MMA gro...
Detailed Description
One of the major challenges in postoperative care following posterior spinal fusion (PSF) for adolescent idiopathic scoliosis (AIS) is achieving adequate pain control. Opioid-sparing multimodal anesth...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- Patients with a diagnosis of adolescent idiopathic scoliosis (AIS) and primary surgical indication between January 2018 and August 2023.
- ASA patients (American Society of Anesthesiology classification) I to III.
- Exclusion criteria:
- Patients who, at the end of the procedure, were transferred to the PICU (Pediatric Intensive Care Unit) on mechanical ventilation.
- Patients undergoing corrective scoliosis surgery in combination with any other surgical procedure.
- Patients who received ESP block postoperatively (Group EM-ESP-G).
Exclusion
Key Trial Info
Start Date :
August 1 2023
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
October 12 2023
Estimated Enrollment :
34 Patients enrolled
Trial Details
Trial ID
NCT06096480
Start Date
August 1 2023
End Date
October 12 2023
Last Update
October 23 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hospital Italiano de Buenos Aires
Ciudad Autonoma de Buenos Aire, Buenos Aires, Argentina, 1199